Pharmaceuticals Based on or Loaded with Natural Products
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".
Deadline for manuscript submissions: 30 November 2024 | Viewed by 68
Special Issue Editor
Interests: ex-vivo permeation; nanosystems; drug delivery systems; biopolymers; buccal tablets; microparticles; dissolution kinetics
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
According to the UN Agenda 2030, several actions (corresponding to 17 Sustainable Development Goals—SDGs) could be taken to act synergistically towards various areas of critical importance for both humanity and the planet. Nowadays, a growing trend is to recover waste, in accordance with a circular economy model, by means of extraction of the loaded or residual natural bioactive compounds (e.g., polyphenols, carotenoids, plant sterols and stanols, anthraquinones, astaxanthin), polymers (e.g., chitosan, hyaluronic acid, pectin), proteins (e.g., collagen, gelatine, fish protein hydrolysate), DNA fractions, lipids, vitamins, etc. These molecules can be successfully used to produce pharmaceuticals as they can exert a wide range of potent biological activities (e.g., antioxidant, antimicrobic, anti-inflammatory, wound healing, antiaging, anti-hyperpigmentation, photoprotective, chemopreventive, anticancer and immunomodulatory) while also being quite safe.
This Special Issue will collect both scientific research papers and review articles focused on the use of the aforementioned natural products obtained by waste recovery to develop pharmaceutical products useful for several purposes. Dermatologic, transdermic, mucosal and oral formulations as well as micro- and nanotechnology-based delivery systems are welcome. The central natural products could be intended as actives (e.g., polyphenols, DNA fractions, fish protein hydrolysate, etc.) or as natural materials to develop the formulation or the nano- and micro-particulate delivery systems (e.g., gelatin, chitosan, hyaluronic acid, pectin, etc.). Contributions to the expansion of knowledge in this context are of great appeal in the pharmaceutical field while also being in agreement with the current “green” trend.
Dr. Giulia Di Prima
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- phytochemicals
- biopolymers
- antioxidants
- pharmaceuticals
- secondary raw materials
- dermatologic formulations
- transdermic formulations
- mucosal formulations
- oral formulations
- micro- and nano-delivery systems
